Skip to main content

Table 4 Univariate and multivariate analysis for all-cause mortality

From: Endovascular treatment in ischemic stroke with active cancer: retrospective analysis of university stroke center data

Characteristic

Univariate Analysis

Multivariate Analysis

OR

95% CI

p-value

OR

95% CI

p-value

Sex

 

Male

1.19

0.69, 2.02

0.5

—

—

 

Active Cancer

 

Yes

1.65

0.75, 3.44

0.2

0.95

0.28, 2.84

> 0.9

Age

1.03

1.01, 1.06

0.008

1.04

1.01, 1.08

0.01

Etiology (Baseline: Cardioembolic)

 

CRS

2.40

0.70, 7.42

0.14

2.86

0.44, 17.7

0.3

Large Artery Atherosclerosis

1.30

0.54, 2.90

0.5

3.21

1.03, 9.92

0.042

Unknown Etiology

1.14

0.61, 2.10

0.7

1.48

0.67, 3.28

0.3

Other

0.00

 

> 0.9

0.00

 

> 0.9

Occlusion

 

Posterior Circulation

1.95

0.87, 4.12

0.09

1.16

0.42, 2.99

0.8

Bridging IVT

0.73

0.40, 1.27

0.3

1.01

0.49, 2.07

> 0.9

Recanalization

 

Unsuccessful (< 2b)

6.26

3.41, 11.6

< 0.001

7.28

3.61, 15.1

< 0.001

History of Cancer

 

Yes

1.06

0.43, 2.33

0.9

—

—

 

Hb

0.86

0.76, 0.97

0.015

0.91

0.79, 1.05

0.2

CRP

1.01

1.00, 1.02

0.003

1.00

0.99, 1.01

0.4

LDH

1.00

1.00, 1.00

0.026

1.00

1.00, 1.00

0.6

INR

1.39

0.50, 3.51

0.5

—

—

 

PTT

1.00

0.99, 1.02

0.6

—

—

 

Platelets

1.00

1.00, 1.00

> 0.9

—

—

 

Hypertension

1.00

1.00, 1.00

> 0.9

—

—

 

Diabetes

1.16

0.60, 2.16

0.6

—

—

 

Prior stroke

1.03

0.51, 1.98

> 0.9

—

—

 

Prophlylaxis at Admission

 

Antiplatelet

1.03

0.51, 1.98

> 0.9

1.03

0.51, 1.98

> 0.9

Dual Treatment

0.87

0.13, 3.59

0.9

1.05

0.14, 5.19

> 0.9

Insufficient

0.46

0.07, 1.72

0.3

0.54

0.07, 2.46

0.5

LMWH

1.11

0.16, 4.90

0.9

0.48

0.04, 3.47

0.5

DOAC

0.72

0.23, 1.90

0.5

0.51

0.13, 1.74

0.3

Paused

2.93

0.90, 9.06

0.063

1.56

0.34, 6.89

0.6

VKA

1.30

0.18, 5.98

0.8

1.66

0.20, 9.07

0.6

NIHSS at Admission

1.06

1.02, 1.10

0.003

1.07

1.01, 1.14

0.019

mRS at Admission

1.28

0.96, 1.77

0.12

0.83

0.52, 1.36

0.5

  1. Abbreviations: CI: Confidence Interval, CRP: C-reactive Protein, CRS: Cancer-Related Stroke, DOAC: direct oral anticoagulants, Hb: hemoglobin, HCT: hematocrit, INR: international normalized ratio, IVT: intravenous thrombolysis, LDH: lactate dehydrogenase, LMWH: low molecular weight heparins, mRS: modified Rankin Scale, NIHSS: National Institute of Health Stroke Scale, OR: Odds Ratio, PTT: partial thromboplastic time, VKA: Vitamin K Antagonists